Access cutting-edge long covid treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access long covid specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related long covid treatment provided free
The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertional malaise, effect of breathlessness on daily activities, post-COVID-19 symptom burden, and biomarkers of inflammation and viral measures, in participants with Long COVID.
Sponsor: Wes Ely
Check if you qualify for this long covid clinical trial in Minneapolis, MN
If you're searching for long covid treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced long covid specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.